Form 8-K - Current report:
SEC Accession No. 0000875045-15-000028
Filing Date
2015-09-01
Accepted
2015-08-31 18:28:52
Documents
2
Period of Report
2015-08-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kcreditfacility2015.htm 8-K 22012
2 EXHIBIT 10.1 creditagreement2015biogen.htm EX-10.1 823651
  Complete submission text file 0000875045-15-000028.txt   847177
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 151085966
SIC: 2836 Biological Products, (No Diagnostic Substances)